VANGUARD GROUP INC

Holdings History for Oruka Therapeutics, Inc. - Common Stock, $0.001 par value (ORKA)

Symbol: ORKA on Nasdaq
Investment type: Equity / Common Stock, $0.001 par value
Latest Disclosed Shares Owned: 2,453,530 shares
Security Ownership %: 5.1%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Oruka Therapeutics, Inc. Common Stock, $0.001 par value (ORKA)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,453,530 shares of Oruka Therapeutics, Inc. Common Stock, $0.001 par value (ORKA). This represents 5.1% ownership of the company. This is the first filing by VANGUARD GROUP INC disclosing ownership of Oruka Therapeutics, Inc. Common Stock, $0.001 par value (ORKA).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
The Vanguard Group	5.1%		$74,366,494	2,453,530			$30.31	13G	31 Dec 2025	30 Jan 2026, 14:20

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$74,366,494	2,453,530	+676,865	+38%	$30.31	Q4 2025
30 Sep 2025	0%	-0%	$34,165,268	1,776,665	-40,642	-2.2%	$19.23	Q3 2025
30 Jun 2025	0%	+0%	$20,372,012	1,817,307	+179,874	+11%	$11.21	Q2 2025
31 Mar 2025	0%	+0%	$16,800,063	1,637,433	+26,782		$10.26	Q1 2025
31 Dec 2024	0%	+0%	$31,230,523	1,610,651	+1,572,853	+4161%	$19.39	Q4 2024
30 Sep 2024	0%	+0%	$926,429	37,798	+37,798	NEW	$24.51	Q3 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.